drugset / Trial / NCT04140006

Efficacy of Antiresorptive and Bone Forming Material on Dental Implants

NCT04140006

Phase 1/2 Unknown 20 enrolled University of Baghdad
RandomizedFactorialOpen-labelTreatment

Summary

Insertion of a metal implant is considered one of the most common surgeries for fracture treatment, joint replacement, and dental implants. The success rate of these implants depends on their fixation which is in turn related primarily on the strength of the bone holding them. Studies evaluating the influence of local application of antiresorptive drugs, like bisphosphonates, on implanted endoprostheses whether orthopedic or dental is increasing annually with more and more experimental studies as well as clinical trials worldwide. On the other hand implants that release medications that enhance bone formation will lead to improved implant fixation and success. The objective of this study was to evaluate the effect of topical application of alendronate sodium gel and recombinant human bone morphogenic protein 2 on dental implant stability and crestal bone level.

Timeline

Start
2019-07-01
Primary completion
2020-07-01
Completion
2020-07-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Alendronic Acid Small molecule 50 ug Topical
Comparator Alendronic Acid Small molecule 100 ug Topical
Comparator rhBMP-2 Protein / enzyme biologic 50 ug Topical
Comparator rhBMP-2 Protein / enzyme biologic 100 ug Topical

Indications

No indication recorded.